Sunil Agarwal MD Overview
Sunil Agarwal MD General Information
Biography
Dr. Sunil Agarwal serves as a Board Member at Arvinas. He serves as a Venture Partner at Forge Life Science Partners. He served as Board Member at Nēsos. He served as Executive Vice President, Head of Development, and Chief Medical Officer at Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines for patients, or Sana, since August 2018. He recently announced he will be departing from Sana in a planned transition after helping to onboard two senior leaders to its research and development organization. From April 2017 to August 2018, he served as President of Research and Development at Juno Therapeutics, a biopharmaceutical company. Previously, he was a Partner at Sofinnova, a biotech-focused investment firm. He also served as a former Executive Vice President and Chief Medical Officer at Ultragenyx Pharmaceutical, a biopharmaceutical company, where he managed the company's clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology, and toxicology functions. Additionally, he previously served in various leadership roles at Genentech, a biotechnology company, for more than a decade, including Senior Vice President and Global Head of Clinical Development for ophthalmology, metabolism, neurosciences, immunology, and infectious diseases. He led the approval of multiple therapies at Genentech including RITUXAN, ACTEMRA, LUCENTIS, and XOLAIR. Earlier in his career, he served at MedImmune and Guilford Pharmaceuticals, both pharmaceutical companies, where he served in both development and medical affairs and led the formation of Guilford's Medical Affairs Organization. He completed his residency at Children's National Medical Center (CNMC), Washington, D.C., and practiced in the CNMC Pediatric Emergency Department. He obtained his B.S. in neurobiology from Cornell University and earned his M.D. from Tufts University School of Medicine.
Contact Information
Address
- 75 State Street
- Suite 1400
- Boston, MA 02109
- United States
Sunil Agarwal MD Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Forge Life Science Partners | Investor | Venture Partner | MA | Venture Capital |
Sunil Agarwal MD Board Seats (3)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Arvinas | Drug Discovery | Publicly Held | Formerly VC-backed | New Haven, CT | |
Astria Therapeutics | Drug Discovery | Publicly Held | Formerly VC-backed | Boston, MA | |
Calithera | Biotechnology | Out of Business | Formerly VC-backed | South San Francisco, CA |
Sunil Agarwal MD Network (81)
Board Members (71)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Andrew Levin Ph.D | Arvinas | RA Capital Management | New Haven, CT | |
Wendy Yarno | MyoKardia | Self | Brisbane, CA | |
Astria Therapeutics | Self | Boston, MA | ||
MyoKardia | Self | Brisbane, CA | ||
Astria Therapeutics | MedImmune Ventures | Boston, MA |
Fund Team Members (10)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Anand Mehra MD | Sofinnova Investments | Sofinnova Venture Partners X | Menlo Park, CA |
Jason Pitts Ph.D | Sofinnova Investments | Sofinnova Venture Partners X | Menlo Park, CA |
Sofinnova Investments | Menlo Park, CA | ||
Sofinnova Investments | Menlo Park, CA | ||
Sofinnova Investments | Menlo Park, CA |
Sunil Agarwal MD Affiliated Funds (1)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Sofinnova Venture Partners X | Sofinnova Investments | Venture - General | Closed | 2016 |
Sunil Agarwal MD FAQs
-
Who is Sunil Agarwal MD?
Dr. Sunil Agarwal serves as a Board Member at Arvinas.
-
How much does Sunil Agarwal MD typically invest?
Sunil Agarwal MD's median deal size is
. -
What is Sunil Agarwal MD’s main position?
Sunil Agarwal MD’s primary position is Board Member.
-
How many active board seats does Sunil Agarwal MD hold?
Sunil Agarwal MD holds 3 board seats including Arvinas, Astria Therapeutics, and Calithera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »